- Original Article
- Open Access
The effect of tranexamic acid on artificial joint materials: a biomechanical study (the bioTRANX study)
© The Author(s) 2014
- Received: 23 March 2014
- Accepted: 28 June 2014
- Published: 5 August 2014
Tranexamic acid (TXA) has been successfully used to reduce bleeding in joint replacement. Recently local TXA has been advocated to reduce blood loss in total knee or hip replacement; however, this raised concerns about potential adverse effects of TXA upon the artificial joint replacement.
Materials and methods
In this biomechanical study we compared the effects of TXA and saline upon the following biomechanical properties of artificial joint materials—(1) tensile properties (ultimate strength, stiffness and Young’s modulus), (2) the wear rate using a multi-directional pin-on-plate machine, and (3) the surface topography of pins and plates before and after wear rate testing.
There were no significant differences in tensile strength, wear rates or surface topography of either ultra-high-molecular-weight polyethylene pins or cobalt chromium molybdenum metal plates between specimens soaked in TXA and specimens soaked in saline.
Biomechanical testing shows that there are no biomechanical adverse affects on the properties of common artificial joint materials from using topical TXA.
Level of evidence
- Tranexamic acid
- Joint replacement
- Blood loss
- Blood transfusion
- Wear rate
- Surface topography
- Biomechanical profile
A major cause of artificial joint failure is the loosening that occurs as a consequence of wear and tear of the bearing surfaces. Even a well performing prosthetic joint releases billions of microscopic wear particles (debris) into the joint space. When an excessive amount of debris is generated it may stimulate a severe body reaction in the capsular tissues and bone leading to inflammation and osteolysis. The resulting loss of supporting bone may lead to loosening of the implants requiring difficult revision surgery.
Most artificial joints consist of two metal surfaces, commonly made of cobalt chromium molybdenum (Co–Cr–Mo) alloy and an insert, commonly made of ultra-high-molecular-weight polyethylene (UHMWPE). The mechanical properties of these two materials are influenced by several chemical and physical factors. Oxidation breaks down the molecular chains in UHMWPE resulting in increased brittleness and reduced resistance to crack propagation. Historically, there have been unfortunate consequences within artificial joints when unexpected and unwanted chemical or physical reactions led to severe wear and joint failure. One example arose from the storage of artificial implants in air-filled packets after sterilisation using gamma radiation. This mode of storage led to gradual oxidation of the UHMWPE and deterioration of its mechanical properties. This was partly overcome by storage within a vacuum-sealed packet. Another example was post-irradiation thermal treatment to reduce free radicals in the polyethylene. This could cause a partial reduction in crystallinity of the material that, in turn, reduced the resistance to crack propagation .
Intravenous tranexamic acid (TXA) has been shown to reduce blood loss and transfusion in joint replacement [2–16]; however, fear of systemic side-effects precludes its wide use in orthopaedic practice. Locally administered TXA has been advocated as a better alternative due its easier preparation and administration, higher concentration at the bleeding site and less systemic side-effects [17–21]. There is a legitimate concern that TXA might adversely affect the biomechanical properties of artificial implants, especially the wear rate which might lead to subsequent loosening and failure. A rigorous search of the published literature, contact with manufacturers and contact with the community publishing on the use of TXA uncovered no research to address this issue. Consequently, this is the first study to investigate the effect of local TXA upon artificial joint biomechanical properties and performance. The research is named the bioTRANX study.
Tensile properties of the UHMWPE (ultimate strength, stiffness and Young’s modulus).
The wear rate using a multi-directional pin-on-plate machine. Pins were made of UHMWPE and plates were made of Co–Cr–Mo.
- 3.The surface topography of pins and plates before and after wear rate testing:
- (a)Peak-valley ratio (PV): the distance between the highest peak and the deepest valley over the entire evaluation length (Fig. 1).
Root mean square roughness (rms): the standard deviation of the surface roughness measurements relative to mean plane of all the data.
- (c)Arithmetic mean roughness (R a ): the average roughness or deviation of all points from a plane (centre line) fitted to the test surface (Fig. 2).
All tested materials are made from identical materials used in the DePuy artificial knee joint replacement (P.F.C.® Sigma® Revision Knee System).
Fifteen dumbbell-shaped tensile specimens were made of UHMWPE—five were soaked in TXA solution (1 g/50 ml saline) for 48 h, five were soaked in 50 ml of saline and the other five were used to standardise the tensile testing machine. The duration of soaking of the tested material was based on the pharmacokinetics properties of TXA in the human body. TXA half-life time is 3.5 h and the human body needs 24 h to clear 90 % of administered TXA.
The plates were made of Co–Cr–Mo. Four plates were fitted to the tray and secured with three metal plates and screws. They were covered with lubricant and heated to 37° C (body temperature). The pins were made of UHMWPE. Each pin was numbered, notched and tightly fitted to the pin holders at the end of each motor. The rotational frequency was also set at 60 cycles/min (1 Hz).
The lubricant used in all tests was a 24.5 % concentration of bovine serum (protein content 15 g/l) and was prepared following a standardised protocol.
A lubricant level sensor was attached to the lubricant tray to allow the lubricant to be maintained at an almost constant level. Any lubricant loss was assumed to be evaporation of water so this was topped up from a reservoir of distilled water. The rotational motion was provided by four small motors. The four loaded pins were held in stainless steel holders and mounted so that each pin rested on the corresponding plate. A load of 40 N was applied to each station via a static mass and lever arm mechanism.
The wear was assessed gravimetrically (loss of weight) and volumetric loss was calculated by dividing the mass by the density. Twice a week (approximately every 0.25 million cycles), the machine was stopped to allow for gravimetric assessment and machine maintenance. The pins and plates were cleaned¸ dried and weighed following a standardised protocol.
Control specimens were used to take account of the absorption of lubricants by both the pins and plates during the test. The wear volumes were plotted against the sliding distance and the gradient of the line provided the wear rate. Wear rate was divided by the load to determine the wear factor, k (mm3/Nm).
The tensile test showed that the stiffness, Young’s modulus, load to fracture and stress at fracture values were not affected by immersion in TXA or saline for 48 h.
Tensile test results of the UHMWPE specimens
P value (95 % CI)
0.740 (−15,146 to 11,218)
Young’s modulus (MPa)
0.740 (−171 to 127)
Load at break (N)
0.523 (17 to −52)
Stress at break (MPa)
0.526 (2 to −7)
The stiffness, Young’s modulus, load to fracture and stress at fracture of the soaked specimens (TXA and saline) were comparable to those of control specimens (non-soaked specimen) (ANOVA; P = 0.79, 0.79, 0.67 and 0.67, respectively).
The wear test involved two multidirectional pin-on-plate machines each with four test stations, four control pins and four control plates which were soaked with saline, and four TXA-soaked pins and four-TXA soaked plates. Another two pins and two plates were used as controls to measure the weight changes caused by lubricant absorption. This was deducted from the test specimens at every gravimetric assessment.
Cumulative volume loss in mm3 in plates and pins
TXA test 1 plate
TXA test 2 plate
Placebo test 1 plate
Placebo test 2 plate
TXA test 1 pin
TXA test 2 pin
Placebo test 1 pin
Placebo test 2 pin
The wear factors of plates and pins; parametric t test
P value (95 % CI)
Plates wear factor
0.768 (−0.161 to 0.023)
Pins wear factor
0.677 (−0.319 to 0.411)
Post wear surface topography findings
P value (95 % CI)
0.856 (−0.5 to 0.4)
0.141 (−0.0284 to 0.0054)
Plates (R a )
0.187 (−0.02 to 0.005)
0.195 (−5.24 to 1.32)
0.612 (−0.542 to 0.3531)
Pins (R a )
0.616 (−0.16 to 0.24)
It may take many years to determine the effectiveness of new and innovative designs of artificial joint replacements since many journals refuse to publish new implants series or interventions with <10 years follow-up. Surgeons are cautious about introducing a new intervention without it being carefully studied and assessed. The history of artificial joint replacement supports this caution.
There has been a recent increase in the use of TXA to reduce bleeding and blood transfusion after joint replacement and, more recently, topical application has been advocated without proper safety profile assessment. In this study we investigated the effects of TXA on three important material properties. Tensile testing and surface topography were studied using gold standard methods. This showed there was no difference in the tensile properties and surface topography between the artificial implants that had been soaked in saline and those soaked with TXA.
There are several methods to assess the rate of wear. Clinical and radiological survival analysis of implanted joints is probably the most useful method; however, it takes an extremely long time as some implants can last >30 years. Furthermore, patients are often lost to follow-up during such a long period. Joint simulation is a reliable predictor but it is expensive with limited access. Multidirectional pin-on-plate machines are a reasonable alternative and several studies have confirmed that they are comparable to joint simulators [23–26].
Comparing results from eight stations, there was no significant difference in the wear factor between the two groups and findings were comparable with the wear factors reported in other studies [23, 27].
Authors acknowledge the fact that biomechanical studies do not always correlate well with the clinical outcomes; however, biomechanical tests are widely accepted as the best available predictors and surrogates for future outcomes. Public expectation is that materials used for health reasons need to be tested mechanically or in animal studies before human use. With increasing medical litigation against health care providers, waiting for clinical outcome studies which may take years may not be the option. This study supports the localised usage of TXA around artificial joints used in humans, while accepting the limitations of a laboratory-based study. Separately, members of the team are investigating the 5-year clinical and radiological outcomes of the first 157 patient who underwent total knee replacement using topical TXA in our centre and this will be reported separately.
In summary, laboratory biomechanical testing shows that there are no biomechanical adverse affects on common artificial joint materials exposed to topical TXA. Nonetheless, surgeons using topical TXA are strongly recommended to be vigilant and encouraged to report unexpected premature joint failures associated with topical use of TXA. The National Joint Registry should collect and analyse data on the use of topical TXA, to help inform on-going research into the safety profile of topical TXA in joint replacement.
The research team would like to thank Dr Roy Harvey and Mr Pete Copley from DePuy International Ltd, Leeds, UK for their support in providing the tested specimens.
Conflict of interest
The bioTRANX study was conducted in the Bioengineering Laboratory of the School of Engineering and Computing Sciences, Durham University, Durham, UK between October 2009 and April 2010. All testing materials were provided free of charge by DePuy International Ltd; however, they did not play any role in the investigation.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
- Fischgrund J (2009) Orthopaedic Knowledge Update, 9th edn. The American Academy of Orthopaedic Surgeons, Rosemont, p 840Google Scholar
- Camarasa MA et al (2006) Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial. Br J Anaesth 96(5):576–582PubMedView ArticleGoogle Scholar
- Jansen AJ et al (1999) Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty. Br J Anaesth 83(4):596–601PubMedView ArticleGoogle Scholar
- Sorin A et al (1999) Reduction of blood loss by tranexamic acid in total knee replacement. J Bone Joint Surg 81-B(Suppl.II):234–234Google Scholar
- Veien M et al (2002) Tranexamic acid given intraoperatively reduces blood loss after total knee replacement: a randomized, controlled study. Acta Anaesthesiol Scand 46(10):1206–1211PubMedView ArticleGoogle Scholar
- Zhang F, Gao Z, Yu J (2007) Clinical comparative studies on effect of tranexamic acid on blood loss associated with total knee arthroplasty. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 21(12):1302–1304PubMedGoogle Scholar
- Benoni G et al (1995) Does tranexamic acid reduce blood loss in knee arthroplasty? Am J Knee Surg 8(3):88–92PubMedGoogle Scholar
- Benoni G, Fredin H (1996) Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients. J Bone Joint Surg Br 78(3):434–440PubMedGoogle Scholar
- Benoni G et al (2001) Blood conservation with tranexamic acid in total hip arthroplasty: a randomized, double-blind study in 40 primary operations. Acta Orthop Scand 72(5):442–448PubMedView ArticleGoogle Scholar
- Benoni G, Lethagen S, Fredin H (1997) The effect of tranexamic acid on local and plasma fibrinolysis during total knee arthroplasty. Thromb Res 85(3):195–206PubMedView ArticleGoogle Scholar
- Benoni G et al (2000) Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty. Acta Orthop Scand 71(3):250–254PubMedView ArticleGoogle Scholar
- Molloy DO et al (2007) Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement: a prospective, randomised controlled trial. J Bone Joint Surg Br 89(3):306–309PubMedView ArticleGoogle Scholar
- Orpen NM et al (2006) Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients. Knee 13(2):106–110PubMedView ArticleGoogle Scholar
- Lozano M et al (2008) Effectiveness and safety of tranexamic acid administration during total knee arthroplasty. Vox Sang 95(1):39–44PubMedView ArticleGoogle Scholar
- Alshryda S et al (2011) Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg Br 93(12):1577–1585PubMedView ArticleGoogle Scholar
- Sukeik M et al (2011) Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg Br 93(1):39–46PubMedView ArticleGoogle Scholar
- Wong J et al (2010) Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg Am 92(15):2503–2513PubMedView ArticleGoogle Scholar
- Ishida K et al (2011) Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty. Int Orthop 35(11):1639–1645PubMedPubMed CentralView ArticleGoogle Scholar
- Alshryda S et al (2013) Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H). J Bone Joint Surg Am 95(21):1969–1974PubMedView ArticleGoogle Scholar
- Alshryda S et al (2013) Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K). J Bone Joint Surg Am 95(21):1961–1968PubMedView ArticleGoogle Scholar
- Panteli M et al (2013) Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis. Knee 20(5):300–309PubMedView ArticleGoogle Scholar
- Ramachandran M (2007) Basic orthopaedic sciences. The Stanmore guide. Hodder Arnold, UK, p 304Google Scholar
- Saikko V (1998) A multidirectional motion pin-on-disk wear test method for prosthetic joint materials. J Biomed Mater Res 41(1):58–64PubMedView ArticleGoogle Scholar
- Joyce TJ et al (2000) A multi-directional wear screening device and preliminary results of UHMWPE articulating against stainless steel. Biomed Mater Eng 10(3–4):241–249PubMedGoogle Scholar
- Scholes SC, Unsworth A (2007) The wear properties of CFR-PEEK-OPTIMA articulating against ceramic assessed on a multidirectional pin-on-plate machine. Proc Inst Mech Eng H 221(3):281–289PubMedView ArticleGoogle Scholar
- Scholes SC, Unsworth A (2001) Pin-on-plate studies on the effect of rotation on the wear of metal-on-metal samples. J Mater Sci Mater Med 12(4):299–303PubMedView ArticleGoogle Scholar
- McKellop H et al (1978) Wear characteristics of UHMW polyethylene: a method for accurately measuring extremely low wear rates. J Biomed Mater Res 12(6):895–927PubMedView ArticleGoogle Scholar